Market Overview

Jefferies & Company Reiterates Buy Rating, $54 PT on Pentair

Related PNR
Biotechs Among Stocks That Insiders Have Been Buying Lately
Earnings Scheduled For October 20, 2015

In a report published Wednesday, Jefferies & Company reiterated its Buy rating and $54.00 price target on Pentair (NYSE: PNR).

Jefferies noted, “PNR's analyst meeting hit the mark, in our view. Management provided guidance for 2013 that captured Street expectations. It lowered the LT sales growth goal but increased the merger synergy target to offset. There is significant heavy lifting ahead, but we believe key targets can be met.”

Pentair closed on Tuesday at $47.60.

Latest Ratings for PNR

Oct 2015Stifel NicolausDowngradesBuy
Oct 2015Morgan StanleyInitiates Coverage onEqual-weight
Oct 2015Goldman SachsReinstatesNeutral

View More Analyst Ratings for PNR
View the Latest Analyst Ratings

Posted-In: Jefferies & CompanyAnalyst Color Reiteration Analyst Ratings


Related Articles (PNR)

Get Benzinga's Newsletters